Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helium/Oxygen vs Nitrogen/Oxygen or NIV in Severe COPD
NCT01355809Phase 2Terminated
- Sponsor
- Air Liquide
- Start
- Dec 2009
- Primary completion
- Mar 2011
- Modality
- GAS (Genetic analysis systems)
- Countries
- 1
01
Overview
A Phase 2 trial of heliox in chronic obstructive pulmonary disease (COPD), sponsored by Air Liquide. Started Dec 2009; status: terminated.
02
Drugs
heliox
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01355809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355809.